Administration of ABHD6 and MAGL inhibitors significantly prevented and reduced CSD-induced periorbital allodynia, suggesting both a new strategy to treat headache pain and supporting prior reports with MAGL inhibitors in other headache models (12). This evidence concerns the gene MGLL and Headache.